Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.81 USD | -0.30% | -1.22% | +24.22% |
May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
May. 08 | Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B | MT |
Business Summary
- provision of development services and clinical supply services (55.4%);
- subcontracted manufacturing services (44.6%).
Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Number of employees: 18,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharma and Consumer Health
53.6
%
| - | - | 2,287 | 53.6 % | - |
Biologics
46.4
%
| 2,549 | 52.8 % | 1,978 | 46.4 % | -22.40% |
Inter-Segment Revenue Elimination
0.0
%
| -17 | -0.4 % | -2 | 0.0 % | -88.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
64.9
%
| 3,110 | 64.4 % | 2,768 | 64.9 % | -11.00% |
Europe
29.5
%
| 1,506 | 31.2 % | 1,257 | 29.5 % | -16.53% |
Other
8.3
%
| 327 | 6.8 % | 355 | 8.3 % | +8.56% |
Elimination of Revenue Attributable to Multiple Locations
-2.7
%
| -115 | -2.4 % | -117 | -2.7 % | +1.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 10-09-30 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 23-07-04 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 19-11-18 | |
Joseph Ferraro
CMP | Compliance Officer | 47 | 23-02-12 |
Charles Lickfold
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-30 |
Paul Surdez
IRC | Investor Relations Contact | - | 20-01-06 |
Ricardo Pravda
PRN | Corporate Officer/Principal | 53 | 04-12-31 |
Michael Hatzfeld
AUD | Comptroller/Controller/Auditor | 51 | Jan. 15 |
Corporate Officer/Principal | 53 | 22-09-18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 14-07-31 |
John Greisch
CHM | Chairman | 68 | 18-02-15 |
J. Carroll
BRD | Director/Board Member | 74 | 15-07-27 |
Jack Stahl
BRD | Director/Board Member | 71 | 14-07-29 |
Donald Morel
BRD | Director/Board Member | 67 | 15-10-31 |
Frank D'Amelio
BRD | Director/Board Member | 66 | 23-08-28 |
Gregory Lucier
BRD | Director/Board Member | 59 | 15-03-31 |
Michael Barber
BRD | Director/Board Member | 64 | 21-04-27 |
Chief Executive Officer | 52 | 10-09-30 | |
Steven Barg
BRD | Director/Board Member | 62 | 23-08-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 181,979,849 | 175,728,677 ( 96.56 %) | 1,000,000 ( 0.5495 %) | 96.56 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.22% | 10.1B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- CTLT Stock
- Company Catalent, Inc.